Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
PLSE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABMDABIOMED, Inc.
-1.78%438.273.3%$601.73m
ISRGIntuitive Surgical, Inc.
-0.08%487.082.4%$423.13m
MDTMedtronic PLC
0.19%86.290.6%$410.62m
ALGNAlign Technology, Inc.
-1.40%359.606.3%$355.86m
SYKStryker Corporation
0.14%169.771.3%$332.60m
BSXBoston Scientific Corporation
-0.28%32.141.1%$312.06m
ABTAbbott Laboratories
-0.64%61.740.8%$311.29m
BDXBecton, Dickinson and Company
1.34%233.201.1%$260.75m
TMOThermo Fisher Scientific Inc.
-1.09%206.521.0%$246.67m
BAXBaxter International Inc.
0.56%73.741.7%$236.10m
EWEdwards Lifesciences Corporation
-1.13%152.161.2%$202.07m
XRAYDENTSPLY International Inc.
-1.24%44.573.0%$132.10m
WATWaters Corporation
0.02%192.983.4%$132.01m
COOCooper Companies, Inc.
0.96%234.062.2%$125.48m
ZBHZimmer Biomet Holdings, Inc.
-0.51%111.521.7%$100.89m

Company Profile

Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Burlingame, CA.